意见反馈 手机随时随地看行情
  • 公司公告

公司公告

昭衍新药:H股公告:关联交易2023-08-31  

         JOINN LABORATORIES (CHINA) CO., LTD.

                                                     6127




  2023    8     30

                3



         2023       9   1   2024    8   31

                               16




                                Joinn Biologics (HK)                       91.07%
8.93% Joinn Biologics (HK) Joinn Biologic Inc                          Joinn Biologic
Inc Joinn Biologic Holdings Ltd.
Joinn Biologic Holdings Ltd. 55% 26%                                Joinn Biologic Inc
     30%                                       Joinn Biologic Inc

                85%
                                                                          A




                                             –1–
                                                             0.1%   5%
                                                                    A




(A)

      2023   8   30

                  3




                      2023        8   30

                      2023        9   1      2026   8   31




                      (i)

                      (ii)

                      (iii)

                      (i)                                                7


                      (ii)
                                  7

                      (iii)
                              7




                                           –2–
(i)                          2,212

(ii)                                      3,250.7

(iii)                                3,852.85

(i)

(ii)


(iii)


                                                                10


(i)                          2023    9     1        2023   9     30

(ii)                                     2023   9     1        2023   11
          30

(iii)                                    2023   9    1         2023   11
          30




(i)

        2023.9.1-2024.8.31           891,878.40

        2024.9.1-2025.8.31           968,856.00

        2025.9.1-2026.8.31           968,856.00




                  –3–
                           (ii)

                                   2023.9.1-2024.8.31              1,629,485.00

                                   2024.9.1-2025.8.31              2,162,771.00

                                   2025.9.1-2026.8.31              2,162,771.00

                           (iii)

                                   2023.9.1-2024.8.31              1,921,067.50

                                   2024.9.1-2025.8.31              2,549,780.50

                                   2025.9.1-2026.8.31              2,549,780.50




                                    (i)

                           (ii)                            (iii)                     (iv)

                                                     (v)




                                                                                  2023
9   1        2026      8    30

                                                                      0.1%
        14A.76(1)(a)




                                             –4–
(B)

      2023   8   30
                      2023     9     1      2024        8   31




                      2023     8     30

                      2023     9     1      2024        8   31




                                          32

                      456.74




                                                                    15




                                          121,195.96




                               (i)

                      (ii)                                  (iii)        (iv)

                                                  (v)




                                          –5–
                      16


                              A




        2,429,000          5,550,000   6,543,000
         16

484,783.84




              –6–
            2008   2   14                          2012 12     26
           A                                          603127         H
                        6127




                                                           Joinn Biologics (HK)
              91.07% 8.93% Joinn Biologics (HK)      Joinn Biologic Inc
       Joinn Biologic Inc Joinn Biologic Holdings Ltd.
                Joinn Biologic Holdings Ltd. 55% 26%                              Joinn
Biologic Inc      30%                                     Joinn Biologic Inc




     85%




                                         –7–
                           Joinn Biologics (HK)                          91.07% 8.93%
Joinn Biologics (HK)Joinn Biologic Inc                           Joinn Biologic Inc Joinn
Biologic Holdings Ltd.                                                       Joinn Biologic
Holdings Ltd. 55% 26%                                 Joinn Biologic Inc     30%
                          Joinn Biologic Inc
                                                                               85%

                                                  A




                                                         0.1%           5%
                                                                    A




                                       –8–
       2023        8   30




2023   9   1


                                       H


                            2023   8       30




           –9–
                                    2023
8   30




                    2023   8   30




                    2023   8   30




         – 10 –
%




    2023   8   30




                    – 11 –